急性缺血性卒中血管内治疗流程与预后改善:MR CLEAN登记研究纵向分析
本研究纳入荷兰MR CLEAN登记研究中前循环近端闭塞并接受血管内治疗的患者,比较第一队列(2014年3月至2016年6月,n=1488)与第二队列(2016年6月至2017年11月,n=1692)的流程时间、再灌注成功率及90天功能预后。第二队列发病至腹股沟穿刺和再灌注时间更短、成功再灌注率更高,功能预后显著改善(校正共同比值比1.23,95%CI 1.07-1.40),校正再灌注时间或成功再灌注后效应减弱。
要点
- 第二队列发病至腹股沟穿刺中位时间185分钟,较第一队列210分钟缩短(P<0.001)。
- 第二队列发病至再灌注中位时间236分钟,较第一队列270分钟缩短(P<0.001)。
- 第二队列成功再灌注率72%,高于第一队列66%(P<0.001);90天功能预后改善(校正共同OR 1.23,95%CI 1.07-1.40)。
核心结论
- 常规临床实践中急性缺血性卒中血管内治疗后的临床预后在过去数年间有所改善,可能源于流程时间缩短和成功再灌注率提高。
研究设计与样本
- 基于MR CLEAN登记研究第一队列(2014年3月至2016年6月,n=1488)和第二队列(2016年6月至2017年11月,n=1692)的纵向研究,纳入前循环近端闭塞接受血管内治疗的患者。
- 比较两队列及按干预日期划分的时间四分位组的流程时间和成功再灌注率。
- 采用多变量序贯logistic回归评估主要结局(90天改良Rankin量表序贯评分)的差异。
主要发现
- 第二队列较第一队列年龄更高、侧支循环更差、CT早期缺血征象更少,其余基线特征相似。
- 第二队列发病至腹股沟穿刺中位时间185分钟 vs 第一队列210分钟(P<0.001);发病至再灌注中位时间236分钟 vs 第一队列270分钟(P<0.001)。
- 第二队列成功再灌注(eTICI 2B-3)率72% vs 第一队列66%(P<0.001)。
- 功能预后显著改善,校正共同OR 1.23(95%CI 1.07-1.40)。
- 校正发病至再灌注时间后效应减弱,校正共同OR 1.12(95%CI 0.98-1.28);校正成功再灌注后效应减弱,校正共同OR 1.13(95%CI 0.99-1.30)。
关键数值与推荐
- 成功再灌注定义为扩展脑梗死溶栓评分(eTICI)2B-3。
- 主要结局为90天改良Rankin量表序贯评分。
- 第一队列n=1488,第二队列n=1692。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We evaluated data from all patients in the Netherlands who underwent endovascular treatment for acute ischemic stroke in the past 3.5 years, to identify nationwide trends in time to treatment and procedural success, and assess their effect on clinical outcomes. METHODS: We included patients with proximal occlusions of the anterior circulation from the second and first cohorts of the MR CLEAN (Multicenter Randomized Clinical trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) Registry (March 2014 to June 2016; June 2016 to November 2017, respectively). We compared workflow times and rates of successful reperfusion (defined as an extended Thrombolysis in Cerebral Infarction score of 2B-3) between cohorts and chronological quartiles (all included patients stratified in chronological quartiles of intervention dates to create equally sized groups over the study period). Multivariable ordinal logistic regression was used to assess differences in the primary outcome (ordinal modified Rankin Scale at 90 days). RESULTS: Baseline characteristics were similar between cohorts (second cohort n=1692, first cohort n=1488) except for higher age, poorer collaterals, and less signs of early ischemia on computed tomography in the second cohort. Time from stroke onset to groin puncture and reperfusion were shorter in the second cohort (median 185 versus 210 minutes; P<0.001 and 236 versus 270 minutes; P<0.001, respectively). Successful reperfusion was achieved more often in the second than in the first cohort (72% versus 66%; P<0.001). Functional outcome significantly improved (adjusted common odds ratio 1.23 [95% CI, 1.07-1.40]). This effect was attenuated by adjustment for time from onset to reperfusion (adjusted common odds ratio, 1.12 [95% CI, 0.98-1.28]) and successful reperfusion (adjusted common odds ratio, 1.13 [95% CI, 0.99-1.30]). Outcomes were consistent in the analysis per chronological quartile. CONCLUSIONS: Clinical outcomes after endovascular treatment for acute ischemic stroke in routine clinical practice have improved over the past years, likely resulting from improved workflow times and higher successful reperfusion rates.
引用
- Compagne KCJ, Kappelhof M, Hinsenveld WH, et al. Improvements in Endovascular Treatment for Acute Ischemic Stroke: A Longitudinal Study in the MR CLEAN Registry. Stroke. 2022. PMID: 35135323. doi:10.1161/STROKEAHA.121.034919
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。